Thyroid C-cell Tumors: In rodent scientific tests, semaglutide has become revealed to trigger thyroid C-cell tumors. It's mysterious regardless of whether this threat relates to humans, but semaglutide is contraindicated in clients with a private or family members record of medullary thyroid carcinoma (MTC) or clients with Many Endocrine Neoplasia